These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 21093891
21. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients. Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N. Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197 [Abstract] [Full Text] [Related]
22. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study. Kovac M, Kovac Z, Tomasevic Z, Vucicevic S, Djordjevic V, Pruner I, Radojkovic D. Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075 [Abstract] [Full Text] [Related]
23. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients. Wahba MA, Ismail MA, Saad AA, Habashy DM, Hafeez ZM, Boshnak NH. Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385 [Abstract] [Full Text] [Related]
31. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746 [Abstract] [Full Text] [Related]
32. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism]. Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont'ev SG, Petukhov EB, Kubatiev AA, Savel'ev VS. Ter Arkh; 2006 May; 78(6):70-6. PubMed ID: 16881367 [Abstract] [Full Text] [Related]
35. Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report. Charafeddine KM, Mahfouz RA, Ibrahim GY, Taher AT, Hoballah JJ, Taha AM. Clin Appl Thromb Hemost; 2010 Oct; 16(5):594-8. PubMed ID: 19520679 [Abstract] [Full Text] [Related]
36. [Mutation frequencies of the thrombophilic state genes in Uzbekistan]. Sadikova ShE, Karimov KhIa, Muminov ShM, Tulakov RP, Boboev KT. Tsitol Genet; 2008 Oct; 42(6):50-4. PubMed ID: 19253755 [Abstract] [Full Text] [Related]
37. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss]. Kovacheva K, Ivanov P, Konova E, Simeonova M, Komsa-Penkova R. Akush Ginekol (Sofiia); 2007 Oct; 46(7):10-6. PubMed ID: 18333414 [Abstract] [Full Text] [Related]
39. Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms. Linfert DR, Tsongalis GJ. Diagn Mol Pathol; 2001 Jun; 10(2):111-5. PubMed ID: 11385320 [Abstract] [Full Text] [Related]
40. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Procare-GEHT Group. Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]